Paper22326498
Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells.
Shimizu H and 5 others. Life Sci, 2012. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells. Papers, record 22326498. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22326498
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemokine CCL2 | Major topic |
| Extracellular Signal-Regulated MAP Kinases | Major topic |
| Indican | Major topic |
| JNK Mitogen-Activated Protein Kinases | Major topic |
| Kidney Tubules | Major topic |
| NF-kappa B | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Animals | |
| Cell Line | |
| Humans | |
| Rats | |
| Rats, Inbred Dahl | |
| Reactive Oxygen Species |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939950 | The Gut-Kidney Axis in Chronic Kidney Disease: Microbial Dysbiosis, Host-Microbial Metabolism, and Emerging Therapeutic Strategies. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939950 | PubMed |
| 42921025 | Research trends and emerging topics in gut microbiota-derived metabolites and diabetic kidney disease: a multi-database bibliometric analysis (2014-2025). | Front Microbiol | 2026 | https://conductscience.org/library/papers/42921025 | PubMed |
| 42511640 | Renal Ischemia-Reperfusion and Uremic Toxins Modulate the Aortic Adenosinergic Axis in Acute Kidney Injury. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511640 | PubMed |
| 42347496 | Sex-Dependent Determinants of Uremic Toxicity in Chronic Kidney Disease. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42347496 | PubMed |
| 42131237 | Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds. | Front Nutr | 2026 | https://conductscience.org/library/papers/42131237 | PubMed |
| 42079406 | Fusobacterium nucleatum as a two-hit amplifier in colorectal cancer pathogenesis: intersection of local and systemic mechanisms via the gut-kidney axis. | Fujita Med J | 2026 | https://conductscience.org/library/papers/42079406 | PubMed |
| 41745738 | Indoxyl Sulfate in the Gut-Kidney Axis: Pathophysiology and Clinical Significance in CKD-Associated Colorectal Cancer. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41745738 | PubMed |
| 41596404 | Thrombospondin 1-CD47 Signalling Modulates Vascular Smooth Muscle Cell Senescence in Chronic Kidney Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596404 | PubMed |
| 40004925 | Benefits and Pitfalls of Uraemic Toxin Measurement in Peritoneal Dialysis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004925 | PubMed |
| 39668321 | Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review. | Probiotics Antimicrob Proteins | 2025 | https://conductscience.org/library/papers/39668321 | PubMed |
| 39574190 | The gut microbiome, chronic kidney disease, and sarcopenia. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39574190 | PubMed |
| 39408756 | Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408756 | PubMed |
| 39378112 | Identification of serum biomarkers for chronic kidney disease using serum metabolomics. | Ren Fail | 2024 | https://conductscience.org/library/papers/39378112 | PubMed |
| 38922148 | Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38922148 | PubMed |
| 38003343 | The AKI-to-CKD Transition: The Role of Uremic Toxins. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003343 | PubMed |
| 37795100 | Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism. | Front Immunol | 2023 | https://conductscience.org/library/papers/37795100 | PubMed |
| 37705914 | Obesity Blunts the Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles. | Kidney Int Rep | 2023 | https://conductscience.org/library/papers/37705914 | PubMed |
| 37676196 | Tryptophan Metabolites Target Transmembrane and Immunoglobulin Domain-Containing 1 Signaling to Augment Renal Tubular Injury. | Am J Pathol | 2023 | https://conductscience.org/library/papers/37676196 | PubMed |
| 37372437 | Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37372437 | PubMed |
| 37189675 | Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney Disease. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189675 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL2 | 6347 | PubTator's text mining | https://conductscience.org/library/genes/6347 | NCBI Gene |
| MAP2K1 | 5604 | PubTator's text mining | https://conductscience.org/library/genes/5604 | NCBI Gene |
| MAP2K2 | 5605 | PubTator's text mining | https://conductscience.org/library/genes/5605 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22326498
GET https://conductscience.org/api/papers/v1/22326498/cited_by?page=2